- Home
- PLNT vs QGEN Comparison
PLNT vs QGEN Comparison
Compare PLNT & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLNT | QGEN |
|---|---|---|
| Founded | 1992 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 10.2B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PLNT | QGEN |
|---|---|---|
| Price | $104.65 | $47.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $118.42 | $50.20 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 02-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | 31.23 | ★ 331.20 |
| EPS | ★ 2.44 | 1.84 |
| Revenue | $1,202,700,000.00 | ★ $2,070,781,000.00 |
| Revenue This Year | $21.43 | $7.07 |
| Revenue Next Year | $11.05 | $6.14 |
| P/E Ratio | $43.24 | ★ $25.56 |
| Revenue Growth | ★ 14.63 | 5.32 |
| 52 Week Low | $87.72 | $37.63 |
| 52 Week High | $114.47 | $51.88 |
Technical Indicators
Market Signals| Indicator | PLNT | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 38.53 | 62.14 |
| Support Level | $103.49 | $44.71 |
| Resistance Level | $110.53 | $46.02 |
| Average True Range (ATR) | 2.30 | 0.73 |
| MACD | -0.90 | 0.21 |
| Stochastic Oscillator | 10.94 | 88.10 |
Price Performance
Historical ComparisonAbout PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).